HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

Glargine and insulin aspart or lispro

TERMINATED · NA · Diabetes Mellitus

The study was started before the official request for protocol registration

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.